雙美生物科技股份有限公司
雙美生物科技股份有限公司為醫學美容膠原蛋白植入劑（Dermal Filler）之領導廠商，專精於生醫級膠原蛋白之純化技術。產品包含面部填充劑及護膚保養品，在台灣及中國大陸市場具有極高知名度。公司成立於 2001 年，總部位於台灣台南。
今日下跌 1.25%，股價跌破短期均線。該股 RSI(6) 為 47.1，處於中性區間，短線無明顯超買超賣訊號。股價站上60日、120日均線，跌破5日、20日均線。短中期均線呈多頭排列，趨勢偏多。KD 指標中性（K=41.7）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 09-24 | -2 | 0 | 0 | -2 |
| 09-22 | -1 | 0 | 0 | -1 |
| 09-21 | -5 | 0 | 0 | -5 |
| 09-18 | -5 | 0 | 0 | -5 |
| 09-17 | -12 | 0 | 0 | -12 |
| 09-16 | -10 | 0 | 0 | -10 |
| 09-15 | -6 | 0 | 0 | -6 |
| 09-08 | -2 | 0 | 0 | -2 |
| 09-07 | +1 | 0 | 0 | +1 |
| 08-31 | -2 | 0 | 0 | -2 |
| 08-24 | +6 | 0 | 0 | +6 |
| 08-20 | 0 | 0 | 0 | 0 |
| 08-18 | +1 | 0 | 0 | +1 |
| 08-17 | -2 | 0 | 0 | -2 |
| 08-14 | 0 | 0 | 0 | 0 |
| 08-13 | -6 | 0 | 0 | -6 |
| 08-11 | +4 | 0 | 0 | +4 |
| 08-10 | -1 | 0 | 0 | -1 |
| 08-07 | +1 | 0 | 0 | +1 |
| 08-06 | +5 | 0 | 0 | +5 |
| 08-05 | +1 | 0 | 0 | +1 |
| 08-04 | +1 | 0 | 0 | +1 |
| 07-31 | +1 | 0 | 0 | +1 |
| 07-30 | -2 | 0 | +2 | -2 |
| 07-29 | -2 | 0 | +2 | -2 |
| 07-28 | -1 | 0 | 0 | -1 |
| 07-24 | -3 | 0 | 0 | -3 |
| 07-23 | -4 | 0 | 0 | -4 |
| 07-21 | +1 | 0 | 0 | +1 |
| 07-20 | +5 | 0 | 0 | +5 |
| 07-17 | +2 | 0 | 0 | +2 |
| 07-16 | +2 | 0 | 0 | +2 |
| 07-06 | 0 | 0 | 0 | 0 |
| 07-01 | 0 | 0 | 0 | 0 |
| 06-30 | +1 | 0 | 0 | +1 |
| 06-26 | 0 | 0 | 0 | 0 |
| 06-25 | -1 | 0 | 0 | -1 |
| 06-24 | 0 | 0 | 0 | 0 |
| 06-22 | -1 | 0 | 0 | -2 |
| 06-18 | -1 | 0 | 0 | -1 |
| 06-16 | 0 | 0 | 0 | 0 |
| 06-11 | -9 | 0 | 0 | -9 |
| 06-10 | -1 | 0 | 0 | -1 |
| 06-09 | +3 | 0 | 0 | +3 |
| 06-08 | +2 | 0 | +1 | +2 |
| 06-05 | +1 | 0 | 0 | +1 |
| 06-04 | 0 | 0 | 0 | 0 |
| 06-03 | 0 | 0 | 0 | 0 |
| 06-02 | -1 | 0 | 0 | -1 |
| 05-29 | +1 | 0 | 0 | +1 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/04 | 2.02 億 | -10.3% | +29.7% |
| 2026/03 | 2.25 億 | +95.8% | +20.1% |
| 2026/02 | 1.15 億 | -48.7% | -30.3% |
| 2026/01 | 2.24 億 | +25.3% | +11.3% |
| 2025/12 | 1.79 億 | +6.5% | +20.2% |
| 2025/11 | 1.68 億 | +4.5% | +21.6% |
| 2025/10 | 1.61 億 | -21.8% | +1.6% |
| 2025/09 | 2.06 億 | +37.2% | +18.9% |
| 2025/08 | 1.50 億 | +1.4% | +0.5% |
| 2025/07 | 1.48 億 | -1.2% | -7.7% |
| 2025/06 | 1.50 億 | -3.0% | -4.9% |
| 2025/05 | 1.54 億 | - | +4.5% |